PROM1 and pancreatic neoplasm: To investigate the effect of low concentrations of metformin on the proliferation of CD133+ pancreatic cancer cells, AsPC-1 and SW1990 cells were treated with 0.2 mM or 0.1 mM metformin, respectively.